RFK Jr orders mifepristone review as anti-abortion groups push for ban [View all]
The US health secretary, Robert F Kennedy Jr, said on Wednesday that he had directed the FDA to review the regulations around the abortion pill mifepristone.
The review, he said, was necessary due to new data data that emerged from a flawed analysis that top US anti-abortion groups are now using to pressure the Trump administration to reimpose restrictions on the abortion pill, if not pull it from the market entirely.
Its alarming, Kennedy told the Missouri senator Josh Hawley, a Republican, during a congressional hearing. Clearly, it indicates that, at very least, the label should be changed.
The analysis, which has not been peer-reviewed or published in a medical journal, came after the Food and Drug Administration commissioner said he was open to reviewing new safety data on the pills, which are used in nearly two-thirds of abortions nationwide.
The conservative organizations are rallying behind a paper published on April 28 by a rightwing thinktank, the Ethics and Public Policy Center, which claims there are higher complication rates from taking mifepristone than previously known.
https://www.theguardian.com/us-news/2025/may/14/rfk-jr-fda-abortion-pill-mifepristone